Scandinavian ChemoTech Investor Relations Material
Latest events
Status Update
Scandinavian ChemoTech
Q1 2025
6 May, 2025
Q4 2024
4 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Scandinavian ChemoTech
Access all reports
Scandinavian ChemoTech is a medical technology company specializing in innovative treatment solutions for cancer and chronic pain. The company develops and markets therapies based on its patented Tumor-Specific Electroporation (TSE) technology, designed to enhance the effectiveness of chemotherapy for specific cancers. Its products are intended to provide minimally invasive and targeted treatments.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
CMOTEC
Country
🇸🇪 Sweden